Pharmaceutical / Drug Definition :
In schizophrenia, therapeutic activity may be mediated through combination of central serotonin2- and dopamine2-receptor antagonism. Drug is a major active metabolite of risperidone.
FDA Label Requirements and Exceptions
FDA Import Information
Paliperidone (Paliperidone Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Paliperidone (Paliperidone Suppliers)
- Processors Paliperidone
- Repackers Paliperidone
- Relabelers Paliperidone
- Exporters Paliperidone
- Importers Paliperidone
For more information about Paliperidone, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.